Dr. Tamas Bartfai directs the Harold L. Dorris Neurological Research Center, which investigates neurological disorders, including schizophrenia and Alzheimer's disease, and which seeks to advance knowledge of the process of aging of the brain.
Lundstrom, L., Sollenberg, U., Brewer, A., Kouya, P. F., Zheng, K., Xu, X. J., Sheng, X., Robinson, J. K., Wiesenfeld-Hallin, Z., Xu, Z. Q., Hokfelt, T., Bartfai, T., et al.
A galanin receptor subtype 1 specific agonistInternational Journal of Peptide Research and Therapeutics2005
11:17-27
DOI:10.1007/s10989-004-1717-z
Bartfai, T., Benovic, J. L., Bockaert, J., Bond, R. A., Bouvier, M., Christopoulos, A., Civelli, O., Devi, L. A., George, S. R., Inui, A., Kobilka, B., Leurs, R., et al.
The state of gpcr research in 2004Nature Reviews Drug Discovery2004
3:574-626
DOI:10.1038/nrd1458
Saar, K., Mazarati, A. M., Mahlapuu, R., Hallnemo, G., Soomets, U., Kilk, K., Hellberg, S., Pooga, M., Tolf, B. R., Shi, T. S., Hokfelt, T., Wasterlain, C., et al.
Anticonvulsant activity of a nonpeptide galanin receptor agonistProceedings of the National Academy of Sciences of the United States of America2002
99:7136-7141
DOI:10.1073/pnas.102163499
Crawley, J. N., Mufson, E. J., Hohmann, J. G., Teklemichael, D., Steiner, R. A., Holmberg, K., Xu, Z. Q. D., Blakeman, K. H., Xu, X. J., Wiesenfeld-Hallin, Z., Bartfai, T., Hokfelt, T.
Galanin overexpressing transgenic miceNeuropeptides2002
36:145-156
DOI:10.1054/npep.2002.0891
Sundgren-Andersson, A. K., Ostlund, P., Bartfai, T.
Il-6 is essential in tnf-alpha-induced feverAmerican Journal of Physiology-Regulatory Integrative and Comparative Physiology1998
275:R2028-R2034
Pooga, M., Jureus, A., Rezaei, K., Hasanvan, H., Saar, K., Kask, K., Kjellen, P., Land, T., Halonen, J., Maeorg, U., Uri, A., Solyom, S., et al.
Novel galanin receptor ligandsJournal of Peptide Research1998
51:65-74
Hokfelt, T., Bartfai, T., Ceccatelli, S., Cortes, R., Fisone, G., Hulting, A. L., Langel, U., Meister, B., Melander, T., Pieribone, V., Schalling, M., Verge, V. M. K., et al.
Central and sensory galanin neurons and functional-aspectsBiomedical Research-Tokyo1992
13:311-317
Hokfelt, T., Millhorn, D., Seroogy, K., Tsuruo, Y., Ceccatelli, S., Lindh, B., Meister, B., Melander, T., Schalling, M., Bartfai, T., Terenius, L.
Coexistence of peptides with classical neurotransmittersExperientia1987
43:768-780
Professor Tamas Bartfai, Ph.D., focuses on two main research areas: 1) the roles of neuropeptide galanin in depression, anxiety, and seizures; and 2) fever, cytokine action in the brain and thermoregulation. The neuropeptide galanin has been found to influence several physiological processes such as cognition and memory, and regulation of mood. This is achieved at three galanin receptor subtypes that control the release of various neurotransmitters and hormones (e.g., acetylcholine, noradrenaline, glutamate, dopamine, insulin, growth hormone, prolactin).
Despite being among the most common pathophysiological signs of disease, we know little about fever. By studying the actions of fever producing substances, pyrogens in the brain, we are learning about fever, an adaptive stress response to microbial infection and to psychological stress. The center of the fever response is the warm sensitive and pyrogen sensitive neuron that is being characterized in great molecular detail; providing insights into how temperature regulation, metabolic rate and aging are correlated. There is a strong emphasis on the translational aspects of the research. Dr Bartfai has been involved in industry and academia in the development of several drugs that are in clinical use and he brings this angle of investigation to each experiment in the laboratory and the department.